These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20430817)

  • 1. Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Delta mutant.
    Panepinto JC; Misener AL; Oliver BG; Hu G; Park YD; Shin S; White TC; Williamson PR
    Microbiology (Reading); 2010 Aug; 156(Pt 8):2558-2565. PubMed ID: 20430817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs.
    Kim J; Cho YJ; Do E; Choi J; Hu G; Cadieux B; Chun J; Lee Y; Kronstad JW; Jung WH
    Fungal Genet Biol; 2012 Nov; 49(11):955-66. PubMed ID: 22975303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole.
    Posteraro B; Sanguinetti M; Sanglard D; La Sorda M; Boccia S; Romano L; Morace G; Fadda G
    Mol Microbiol; 2003 Jan; 47(2):357-71. PubMed ID: 12519188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.
    Paul S; Doering TL; Moye-Rowley WS
    Fungal Genet Biol; 2015 Jan; 74():1-9. PubMed ID: 25445311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.
    Chang M; Sionov E; Khanal Lamichhane A; Kwon-Chung KJ; Chang YC
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378705
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans.
    Sanguinetti M; Posteraro B; La Sorda M; Torelli R; Fiori B; Santangelo R; Delogu G; Fadda G
    Infect Immun; 2006 Feb; 74(2):1352-9. PubMed ID: 16428784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
    Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
    Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Ghaffar M; Orr C; Webb G
    PLoS One; 2019; 14(12):e0225701. PubMed ID: 31800598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
    Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
    Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans.
    Xu J; Onyewu C; Yoell HJ; Ali RY; Vilgalys RJ; Mitchell TG
    Antimicrob Agents Chemother; 2001 Feb; 45(2):420-7. PubMed ID: 11158735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii.
    Lockhart SR; Fothergill AW; Iqbal N; Bolden CB; Grossman NT; Garvey EP; Brand SR; Hoekstra WJ; Schotzinger RJ; Ottinger E; Patterson TF; Wiederhold NP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2528-31. PubMed ID: 26787697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment.
    Sionov E; Chang YC; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5127-30. PubMed ID: 23836187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner.
    Semighini CP; Averette AF; Perfect JR; Heitman J
    PLoS Pathog; 2011 Nov; 7(11):e1002364. PubMed ID: 22114551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aneuploidy underlies brefeldin A-induced antifungal drug resistance in
    Zhang ZH; Sun LL; Fu BQ; Deng J; Jia CL; Miao MX; Yang F; Cao YB; Yan TH
    Front Cell Infect Microbiol; 2024; 14():1397724. PubMed ID: 38966251
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
    Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
    Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans.
    Lee H; Khanal Lamichhane A; Garraffo HM; Kwon-Chung KJ; Chang YC
    Mol Microbiol; 2012 Apr; 84(1):130-46. PubMed ID: 22339665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creation, characterization and utilization of Cryptococcus neoformans mutants sensitive to micafungin.
    Toh-E A; Ohkusu M; Shimizu K; Yamaguchi M; Ishiwada N; Watanabe A; Kamei K
    Curr Genet; 2017 Dec; 63(6):1093-1104. PubMed ID: 28560585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans.
    Dbouk NH; Covington MB; Nguyen K; Chandrasekaran S
    BMC Microbiol; 2019 Nov; 19(1):243. PubMed ID: 31694529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation.
    Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
    FEMS Yeast Res; 2012 Nov; 12(7):748-54. PubMed ID: 22731401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
    Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.